1-4 of 4
Benjamin J. Gigliotti
Close
Sort by
Journal Articles

In vivo prostaglandin E 2 treatment alters the bone marrow microenvironment and preferentially expands short-term hematopoietic stem cells

Benjamin J. Frisch, Rebecca L. Porter, Benjamin J. Gigliotti, Adam J. Olm-Shipman, Jonathan M. Weber, Regis J. O'Keefe, Craig T. Jordan, Laura M. Calvi
Journal: Blood
Blood (2009) 114 (19): 4054–4063.
https://doi.org/10.1182/blood-2009-03-205823
Published: 2009
Includes: Supplemental data
Journal Articles

In Vivo Treatment with Prostaglandin E 2 (PGE2) Selectively Expands Short-Term Hematopoietic Stem Cells.

Benjamin J. Frisch, BS, Jonathan M. Weber, B.S., Rebecca L. Porter, B.S., Benjamin J. Gigliotti, B.S., Julianne N. Smith, Adam J. Olm-Shipman, B.S., Regis J. O’Keefe, M.D., PhD, Craig T. Jordan, PhD, Laura M. Calvi, M.D.
Journal: Blood
Blood (2007) 110 (11): 1254.
https://doi.org/10.1182/blood.V110.11.1254.1254
Published: 2007
Journal Articles

Prostaglandin E 2 (PGE2) Regulates Osteoblastic Jagged1 and Expands Primitive Hematopoietic Cells In Vivo.

Laura M. Calvi, MD, Benjamin J. Frisch, Benjamin J. Gigliotti, Christina A. Christianson, Jonathan M. Weber, Craig T. Jordan, PhD, Regis J. O’Keefe, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 89.
https://doi.org/10.1182/blood.V108.11.89.89
Published: 2006
Journal Articles

Osteoblastic Cells (OBs) and the Hematopoietic Microenvironment: Parathyroid Hormone (PTH) Increases the Notch Ligand Jagged1 (J1) in a Specific Subpopulation of OBs.

Shaula R. Forsythe, Jonathan M. Weber, Christina A. Christianson, Benjamin J. Gigliotti, Benjamin J. Frisch, Laura M. Calvi, MD
Journal: Blood
Blood (2005) 106 (11): 1396.
https://doi.org/10.1182/blood.V106.11.1396.1396
Published: 2005